Registration and prospectus / Lifecore Biomedical, Inc. | Tables in SEC filings

LFCR Lifecore Biomedical, Inc.

IPO registration


	Shares Beneficially Owned Prior to the Offering (1)				Maximum Number of Shares to be Sold Pursuant to this Prospectus (2)	Shares Beneficially Owned After the Offering (3)
Name of Selling Stockholder	Shares		Percentage			Shares	Percentage
22NW, LP	4,099,530	(4)	10.5	%	335,446	4,099,530	10.2	%
325 Capital	1,574,137	(5)	4.2	%	904,496	781,456	2.0	%
Bradley L. Radoff	243,902	(6)	*		243,902	—	—
Clark BP, LLC	519,629	(7)	1.4	%	166,009	353,620	*
Cove Street Capital, LLC	1,608,157	(8)	4.3	%	67,089	1,608,157	4.2	%
David Capital Partners Fund, LP	1,855,000	(9)	5.0	%	500,000	1,355,000	3.6	%
David S. Floren	71,104	(10)	*		10,000	61,104	*
DCF Partners, L.P.	658,478	(11)	1.8	%	370,000	288,478	*
Far View Partners LP	657,848	(12)	1.8	%	182,926	474,922	1.3	%
Foxhunt Crescent, LP	868,640	(13)	2.4	%	121,951	746,689	2.0	%
Greenhaven Road Capital Fund 1, LP	1,668,504	(14)	4.5	%	646,308	1,022,196	2.7
Greenhaven Road Capital Fund 2, LP	2,023,694	(15)	5.5	%	817,106	1,206,588	3.2
Laughing Water Capital, LP	485,617	(16)	1.3	%	153,973	331,644	*
Laughing Water Capital II, LP	525,652	(17)	1.4	%	167,822	357,830	*
Legion Partners Asset Management, LLC	6,385,464	(18)	16.5	%	1,742,952	4,922,050	12.4	%
Wynnefield Capital, Inc.	5,211,663	(19)	14.0	%	365,364	4,918,980	12.9	%

Table search / Registration and prospectus / Lifecore Biomedical, Inc.